Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Tamussino, KF; Gücer, F; Reich, O; Moser, F; Petru, E; Scholz, HS.
Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma.
Int J Gynecol Cancer. 2001; 11(3):236-240
Doi: 10.1046%2Fj.1525-1438.2001.01024.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Führende Autor*innen der Med Uni Graz
- Tamussino Karl
- Co-Autor*innen der Med Uni Graz
- Petru Edgar
- Reich Olaf
- Scholz Heinz
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- We analyzed whether a low pretreatment hemoglobin level is a prognostic factor in endometrial cancer and whether it is associated with thrombocytosis. Two hundred and twelve patients with endometrial cancer treated with surgery were reviewed. Data were analyzed with Pearson's chi-squared test, Fisher's exact test in contingency tables, the Mann-Whitney U-test, the Student's t-test, and Kaplan-Meier estimates. Multivariate analysis was performed with the log-rank test and the Cox proportional hazard model. Thirty-nine patients (18%) had a pretreatment hemoglobin value of < 12.0 g/dL. These 39 patients had significantly higher rates of nonendometrioid histology, high-grade tumors, myometrial invasion of > 50%, adnexal involvement, lymph-vascular space involvement, and advanced FIGO stage than patients with hemoglobin > or = 12.0 g/dL. The rate of thrombocytosis was significantly higher in patients with a low hemoglobin level (36% vs. 8%, P < 0.01). The overall 5-year survival rate of patients with low pretreatment hemoglobin was 59% compared with 89% for those with hemoglobin > or = 12 g/dL (P < 0.01). In the multivariate analysis age, thrombocytosis, nonendometrioid histology, high-grade histology, and advanced FIGO stage were significantly associated with a poor prognosis whereas adnexal involvement, lymph-vascular space involvement, low hemoglobin and myometrial invasion were not. These data indicate that low pretreatment hemoglobin is a prognostic factor in patients with endometrial cancer and that it is associated with thrombocytosis. Low hemoglobin was strongly associated with other unfavorable prognostic factors so that it was significant in the univariate but not the multivariate analysis.
- Find related publications in this database (using NLM MeSH Indexing)
- Endometrial Neoplasms - blood
- Female - blood
- Hemoglobins - blood
- Humans - blood
- Middle Aged - blood
- Neoplasm Staging - blood
- Platelet Count - blood
- Predictive Value of Tests - blood
- Prognosis - blood
- Survival Analysis - blood
- Thrombocytosis - diagnosis
- Find related publications in this database (Keywords)
- anemia
- endometrial cancer
- thrombocytosis